4,4',4'',4'''-(Ethane-1,1,2,2-tetrayl)tetraphenol, 95.0%, 250mg

4-Methoxy-2-[(piperidin-4-yl)methoxy]pyridine dihydrochloride, 1g

6-Bromo-2,2-dimethyl-3,4-dihydro-2H-benzo[b][1,4]oxazine, 95.0%, 250mg

5-BROMOPYRAZOLO[1,5-A]PYRIDINE-2-CARBOXYLIC ACID, 95.0%, 1g

Oxetane-3-thiol, 95.0%, 500mg

GC-Kapillarsäule ROTI®Cap-5, unpolar, L 60 m, Ø-Innen 0,32 mm, Filmd. 0,25 µm, 1 Stück

4-Bromo-n-(2-iodophenyl)benzenesulfonamide, 95%, 100mg

1,1,4,4,6-Pentamethyl-1,2,3,4-tetrahydronaphthalene, 97.0%, 100g

6,6-Dimethylpiperidine-2,4-dione, 95.0%, 5g

2-Methoxypyrimidine, 95.0%, 25g

Fmoc-L-Tryptophan-(Boc), PEPTIPURE®, min. 97 %, für die Biochemie, 5 g, Glasverpackung

(1R)-1-(4-tert-butylphenyl)ethan-1-amine, 95%, 1g

4-ETHYNYL-1H-PYRAZOLE, 95.0%, 25g